FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082296670> ?p ?o ?g. }

• W3082296670 endingPage "277" @default.
• W3082296670 startingPage "267" @default.
• W3082296670 abstract "Background MicroRNAs have been reported to play regulatory functions in various cancers, including esophageal cancer. The aim of this study was to investigate the effects of miR-140 on the progression of esophageal cancer and the underlying regulatory mechanism. Methods The levels of miR-140 and zinc finger E-box-binding homeobox 2 (ZEB2) messenger RNA in esophageal cancer tissues and cell lines were measured by quantitative real-time polymerase chain reaction. The protein levels of ZEB2, β-catenin, c-Myc, and cyclinD1 were determined by Western blot. Cell proliferation and apoptosis were determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide assay and flow cytometry, respectively. Cell migration and invasion were assessed by transwell assay. In addition, the relationship between miR-140 and ZEB2 was predicted by TargetScan online database and confirmed by dual-luciferase reporter assay. The tumor xenograft model was used to verify the role of miR-140 in esophageal cancer progression in vivo. Results The expression of miR-140 was downregulated whereas ZEB2 expression was upregulated in esophageal cancer tissues compared with paracancerous normal tissues. Functionally, both miR-140 overexpression and ZEB2 knockdown inhibited proliferation, migration, and invasion and induced apoptosis in esophageal cancer cells. ZEB2 overexpression reversed the effects of miR-140 on proliferation, apoptosis, migration, and invasion of esophageal cancer cells. Mechanistically, ZEB2 was identified as a target of miR-140. Furthermore, miR-140 suppressed Wnt/β-catenin pathway by regulating ZEB2 expression in esophageal cancer cells. MiR-140 inhibited tumor growth of esophageal cancer through repressing ZEB2 expression in vivo. Conclusions Our results demonstrated that miR-140 inhibited esophageal cancer development by targeting ZEB2 through inactivating Wnt/β-catenin pathway." @default.
• W3082296670 created "2020-09-08" @default.
• W3082296670 creator A5023183433 @default.
• W3082296670 creator A5032447166 @default.
• W3082296670 creator A5060696709 @default.
• W3082296670 creator A5068386954 @default.
• W3082296670 creator A5080634111 @default.
• W3082296670 creator A5088910755 @default.
• W3082296670 date "2021-01-01" @default.
• W3082296670 modified "2023-10-16" @default.
• W3082296670 title "MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway" @default.
• W3082296670 cites W1992429870 @default.
• W3082296670 cites W1996892129 @default.
• W3082296670 cites W2006419043 @default.
• W3082296670 cites W2009719239 @default.
• W3082296670 cites W2013035261 @default.
• W3082296670 cites W2016346780 @default.
• W3082296670 cites W2022519281 @default.
• W3082296670 cites W2040759130 @default.
• W3082296670 cites W2062831570 @default.
• W3082296670 cites W2106878555 @default.
• W3082296670 cites W2144149602 @default.
• W3082296670 cites W2158942213 @default.
• W3082296670 cites W2327517543 @default.
• W3082296670 cites W2341260762 @default.
• W3082296670 cites W2563470051 @default.
• W3082296670 cites W2589432396 @default.
• W3082296670 cites W2607187515 @default.
• W3082296670 cites W2767436434 @default.
• W3082296670 cites W2773579020 @default.
• W3082296670 cites W2782430302 @default.
• W3082296670 cites W2788200616 @default.
• W3082296670 cites W2791195074 @default.
• W3082296670 cites W2897535406 @default.
• W3082296670 cites W2915092146 @default.
• W3082296670 cites W2946496403 @default.
• W3082296670 cites W2949072231 @default.
• W3082296670 cites W2959218333 @default.
• W3082296670 cites W2960898128 @default.
• W3082296670 cites W2962856175 @default.
• W3082296670 cites W2968228271 @default.
• W3082296670 cites W4211048478 @default.
• W3082296670 cites W888052947 @default.
• W3082296670 doi "https://doi.org/10.1016/j.jss.2020.07.074" @default.
• W3082296670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32862055" @default.
• W3082296670 hasPublicationYear "2021" @default.
• W3082296670 type Work @default.
• W3082296670 sameAs 3082296670 @default.
• W3082296670 citedByCount "21" @default.
• W3082296670 countsByYear W30822966702021 @default.
• W3082296670 countsByYear W30822966702022 @default.
• W3082296670 countsByYear W30822966702023 @default.
• W3082296670 crossrefType "journal-article" @default.
• W3082296670 hasAuthorship W3082296670A5023183433 @default.
• W3082296670 hasAuthorship W3082296670A5032447166 @default.
• W3082296670 hasAuthorship W3082296670A5060696709 @default.
• W3082296670 hasAuthorship W3082296670A5068386954 @default.
• W3082296670 hasAuthorship W3082296670A5080634111 @default.
• W3082296670 hasAuthorship W3082296670A5088910755 @default.
• W3082296670 hasConcept C104317684 @default.
• W3082296670 hasConcept C121608353 @default.
• W3082296670 hasConcept C137620995 @default.
• W3082296670 hasConcept C137738243 @default.
• W3082296670 hasConcept C145059251 @default.
• W3082296670 hasConcept C1491633281 @default.
• W3082296670 hasConcept C153911025 @default.
• W3082296670 hasConcept C173396325 @default.
• W3082296670 hasConcept C185592680 @default.
• W3082296670 hasConcept C190283241 @default.
• W3082296670 hasConcept C2779742542 @default.
• W3082296670 hasConcept C502942594 @default.
• W3082296670 hasConcept C54355233 @default.
• W3082296670 hasConcept C553184892 @default.
• W3082296670 hasConcept C55493867 @default.
• W3082296670 hasConcept C62112901 @default.
• W3082296670 hasConcept C62478195 @default.
• W3082296670 hasConcept C86803240 @default.
• W3082296670 hasConcept C95444343 @default.
• W3082296670 hasConceptScore W3082296670C104317684 @default.
• W3082296670 hasConceptScore W3082296670C121608353 @default.
• W3082296670 hasConceptScore W3082296670C137620995 @default.
• W3082296670 hasConceptScore W3082296670C137738243 @default.
• W3082296670 hasConceptScore W3082296670C145059251 @default.
• W3082296670 hasConceptScore W3082296670C1491633281 @default.
• W3082296670 hasConceptScore W3082296670C153911025 @default.
• W3082296670 hasConceptScore W3082296670C173396325 @default.
• W3082296670 hasConceptScore W3082296670C185592680 @default.
• W3082296670 hasConceptScore W3082296670C190283241 @default.
• W3082296670 hasConceptScore W3082296670C2779742542 @default.
• W3082296670 hasConceptScore W3082296670C502942594 @default.
• W3082296670 hasConceptScore W3082296670C54355233 @default.
• W3082296670 hasConceptScore W3082296670C553184892 @default.
• W3082296670 hasConceptScore W3082296670C55493867 @default.
• W3082296670 hasConceptScore W3082296670C62112901 @default.
• W3082296670 hasConceptScore W3082296670C62478195 @default.
• W3082296670 hasConceptScore W3082296670C86803240 @default.
• W3082296670 hasConceptScore W3082296670C95444343 @default.
• W3082296670 hasFunder F4320326693 @default.

• next